Cargando…
Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
BACKGROUND: The mutational processes underlying non-coding cancer mutations and their biological significance in tumor evolution are poorly understood. To get better insights into the biological mechanisms of mutational processes in breast cancer, we integrate whole-genome level somatic mutations fr...
Autores principales: | Yang, Jiekun, Wei, Xiaolong, Tufan, Turan, Kuscu, Cem, Unlu, Hayrunnisa, Farooq, Saadia, Demirtas, Elif, Paschal, Bryce M., Adli, Mazhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223090/ https://www.ncbi.nlm.nih.gov/pubmed/30404658 http://dx.doi.org/10.1186/s13059-018-1572-4 |
Ejemplares similares
-
Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
por: Singh, Ritambhara, et al.
Publicado: (2015) -
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
por: Szlachta, Karol, et al.
Publicado: (2018) -
Tip60 acetylation of histone H3K4 temporally controls chromosome passenger complex localization
por: Niedzialkowska, Ewa, et al.
Publicado: (2022) -
Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9
por: Qin, Peiwu, et al.
Publicado: (2017) -
The Proteasome Inhibitor Bortezomib Induces an Inhibitory Chromatin Environment at a Distal Enhancer of the Estrogen Receptor-α Gene
por: Powers, Ginny L., et al.
Publicado: (2013)